Task: Answer the multiple choice question.
Question: Which drug exhibits a 16.567% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a COC(=O)N/N=C/c1c(C)cc(C)cc1C
b C[N+](C)(C)CCNC(=O)c1c(O)c2c([nH]c1=O)CCCC2.[I-]
c COCc1nnc(SCC(=O)NCc2ccccc2)n1-c1ccccc1
d COc1ccccc1-n1cnnc1SCC(=O)NCC1CCCO1
Answer: d. COc1ccccc1-n1cnnc1SCC(=O)NCC1CCCO1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1-n1cnnc1SCC(=O)NCC1CCCO1
COc1ccccc1-n1cnnc1SCC(=O)NCC1CCCO1
2-[[4-(2-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]-N-(oxolan-2-ylmethyl)acetamide